Replies to post #208644 on Biotech Values

[biotech_researcher]

"Survey...Who will obtain FDA approval for any interchangeable FoB during the next 5 years? "

Dew, 5 years is an eternity in the biotech world...

[DewDiligence]

Survey results (30 votes)…

Q: Who will obtain FDA approval for any
interchangeable FoB during the next 5 years?


a) No one: 7%
b) Only MNTA (possibly with a partner): 40%
c) Multiple companies: 53%


Thanks to all of the participants for participating.

[DewDiligence]

New survey: Potential ABBV-MNTA Humira Settlement

Q: If MNTA gets FDA approval for an interchangeable Humira FoB by the end of 2018 and no other company achieves this, will MNTA and ABBV reach a settlement enabling MNTA to launch before 2022?

a) Almost certainly
b) Likely
c) Unlikely but possible
d) No chance


Please see #msg-118144295, #msg-118781959, #msg-129261201, #msg-131412917, and #msg-131414987 for background info.


To vote, please go to
http://investorshub.advfn.com/boards/board_surveymenu.asp?board_id=1418
and select survey #166.